EXECUTIVE ENGAGEMENTS
POOL
3953
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
712
Interactions with Platform & by Email
PARTICIPANTS
119
Unique # Participated
VALIDATIONS
34
Responses Validated*
COMPANIES
41
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
223
PAGES
294
EDITION
8
PRICE
USD 4950
CODE
MCP16214
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Biopharmaceutical Fermentation Systems Market to Reach $14.8 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Biopharmaceutical Fermentation Systems estimated at US$10.9 Billion in the year 2020, is projected to reach a revised size of US$14.8 Billion by 2027, growing at aCAGR of 4.5% over the period 2020-2027. Upstream Products, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$5.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Downstream Products segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 4.3% CAGR
The Biopharmaceutical Fermentation Systems market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
SELECT PLAYERS
Becton, Dickinson and Company; Eppendorf AG; F. Hoffmann-La Roche AG; GE Healthcare; Lonza Group AG; Merck KgaA; Nova Biomedical Corporation; Sartorius Stedim Biotech SA; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications) » End-Use (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry, Other End-Uses) » Product (Upstream Products, Downstream Products)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Biopharmaceutical Fermentation Systems – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Upstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Downstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Recombinant Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Manufacturing Organizations (CMOs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic and Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Food Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Biopharmaceutical Fermentation Systems Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| JAPAN |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| CHINA |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| EUROPE |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| FRANCE |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| GERMANY |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Biopharmaceutical Fermentation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com